Corporate Profile
Focusing on PCR,NGS,ELISA and lateral flow rapid test kits including food safety test kits, human and animal infectious disease diagnostic kits in US for 12 years.
REAGEN manufactures innovative diagnostic kits for detection of antibiotics, veterinary drugs, mycotoxins, algal toxins, estrogens, pesticides, industrial pollutants, infectious diseases, as well as raw materials for molecular diagnostics and immunoassays. Our diagnostic systems are fast and easy to operate and designed to efficiently guarantee the quality of the assays in the laboratory.
Past Events
REAGEN recently participated in activities.
IAFP
Each year the International Association for Food Protection (IAFP) holds an Annual Conference to provide attendees with relevant information on current and emerging food safety issues, the latest science, and innovative solutions to new and recurring problems.
MEDICA
REAGEN brings IVD product testing solutions to communicate and learn from exhibiting professionals from all over the world at MEDICA.
WHX
World Health Expo (WHX) is the world’s largest network of healthcare events, where the brightest minds come together to shape the future of health. With 15 international events across the world, WHX connects people, governments, businesses, and ideas on a global scale, enabling discovery, innovation and opportunity.
REAGEN INVESTORS
The following is a list of REAGEN investors’ shareholding ratios:
Max Deng
•Bachelor of Life Science;
•Has been engaged in biotechnology product business in the United States and China for a long time;
•Has more than 20 years of experience in food safety and in vitro diagnostics industry,Has a deep understanding of market demand and development direction;
Background experience:
2008—2009: General Manager of TEKBIO http://www.tekbio.cn/.
2009—2022: General Manager of REAGEN http://reagen.cn.
2022—2025: CEO of REAGEN, INC https://reagen.us.
Pasaca Capital
Primarily focused on equity investments, Pasaca targets innovative technologies and products and help their inventors maximize their commercial values in global market through funding, strategic transformations and formulate and execute global marketing strategies.
INNOVA Medical Group
As a leader in the research and development of in-vitro diagnostic reagents and test kits, Innova has improved lives with testing, monitoring, and implementing medical care. Innova Medical Group is a wholly owned subsidiary of Pasaca Capital, Inc. and is headquartered in Pasadena, CA.
Michelle
Over 10 years of research experience in Molecular biology, Genetics, Physiology, Pharmacology,cellular and in multiple multidisciplinary projects and research area.
Aidan
Master of Science in Immunology with experience in cell therapy, molecular engineering, autoimmune diagnostics, and infectious disease
Leo Cao
Graduated from Nanyang Agricultural Vocational College, engaged in factory management for more than 10 years.
Victor
Proficient in the application and registration process of diagnostic reagent products, successfully declared 37 items of second-class diagnostic reagent products in a year and a half.
Cindy
10 years of human resources and administrative management experience in listed companies, leading system establishment, team building and corporate culture promotion.
Gump Deng
Engaged in food safety related industry for more than 20 years, has a wealth of work experience.
Zhimin Liu
Graduated from Guangdong Pharmaceutical University, engaged in colloidal gold project research and development for 8 years, has rich agent team ability and kit research and development experience.
Cheng Xu, PhD
PhD in Veterinary Medicine from the Norwegian University of Life Sciences.He has published more than 20 SCI papers in international core journals
KK
Graduated from Guilin Medical College, engaged in food safety industry for more than 15 years, long-term engaged in ELISA kit project technical services